Literature DB >> 10716930

Molecular determinants that mediate selective activation of p38 MAP kinase isoforms.

H Enslen1, D M Brancho, R J Davis.   

Abstract

The p38 mitogen-activated protein kinase (MAPK) group is represented by four isoforms in mammals (p38alpha, p38beta2, p38gamma and p38delta). These p38 MAPK isoforms appear to mediate distinct functions in vivo due, in part, to differences in substrate phosphorylation by individual p38 MAPKs and also to selective activation by MAPK kinases (MAPKKs). Here we report the identification of two factors that contribute to the specificity of p38 MAPK activation. One mechanism of specificity is the selective formation of functional complexes between MAPKK and different p38 MAPKs. The formation of these complexes requires the presence of a MAPK docking site in the N-terminus of the MAPKK. The second mechanism that confers signaling specificity is the selective recognition of the activation loop (T-loop) of p38 MAPK isoforms. Together, these processes provide a mechanism that enables the selective activation of p38 MAPK in response to activated MAPKK.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716930      PMCID: PMC305671          DOI: 10.1093/emboj/19.6.1301

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  52 in total

Review 1.  Protein modification: docking sites for kinases.

Authors:  P M Holland; J A Cooper
Journal:  Curr Biol       Date:  1999-05-06       Impact factor: 10.834

2.  The search for physiological substrates of MAP and SAP kinases in mammalian cells.

Authors:  P Cohen
Journal:  Trends Cell Biol       Date:  1997-09       Impact factor: 20.808

Review 3.  p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials.

Authors:  J C Lee; S Kassis; S Kumar; A Badger; J L Adams
Journal:  Pharmacol Ther       Date:  1999 May-Jun       Impact factor: 12.310

4.  Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase.

Authors:  D Jacobs; D Glossip; H Xing; A J Muslin; K Kornfeld
Journal:  Genes Dev       Date:  1999-01-15       Impact factor: 11.361

5.  A conserved motif at the amino termini of MEKs might mediate high-affinity interaction with the cognate MAPKs.

Authors:  L Bardwell; J Thorner
Journal:  Trends Biochem Sci       Date:  1996-10       Impact factor: 13.807

Review 6.  Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development.

Authors:  Y T Ip; R J Davis
Journal:  Curr Opin Cell Biol       Date:  1998-04       Impact factor: 8.382

7.  Identification and characterization of a predominant isoform of human MKK3.

Authors:  J Han; X Wang; Y Jiang; R J Ulevitch; S Lin
Journal:  FEBS Lett       Date:  1997-02-10       Impact factor: 4.124

8.  Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.

Authors:  M Hibi; A Lin; T Smeal; A Minden; M Karin
Journal:  Genes Dev       Date:  1993-11       Impact factor: 11.361

9.  Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family.

Authors:  Y Wang; S Huang; V P Sah; J Ross; J H Brown; J Han; K R Chien
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

10.  Direct suppression of TCR-mediated activation of extracellular signal-regulated kinase by leukocyte protein tyrosine phosphatase, a tyrosine-specific phosphatase.

Authors:  M Oh-hora; M Ogata; Y Mori; M Adachi; K Imai; A Kosugi; T Hamaoka
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

View more
  74 in total

1.  A conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmission.

Authors:  A J Bardwell; L J Flatauer; K Matsukuma; J Thorner; L Bardwell
Journal:  J Biol Chem       Date:  2000-12-28       Impact factor: 5.157

2.  CaMKII is involved in cadmium activation of MAPK and mTOR pathways leading to neuronal cell death.

Authors:  Sujuan Chen; Yijiao Xu; Baoshan Xu; Min Guo; Zhen Zhang; Lei Liu; Hongwei Ma; Zi Chen; Yan Luo; Shile Huang; Long Chen
Journal:  J Neurochem       Date:  2011-10-20       Impact factor: 5.372

3.  Cytoplasmic localization of Wis1 MAPKK by nuclear export signal is important for nuclear targeting of Spc1/Sty1 MAPK in fission yeast.

Authors:  Aaron Ngocky Nguyen; Aminah D Ikner; Mitsue Shiozaki; Sasha M Warren; Kazuhiro Shiozaki
Journal:  Mol Biol Cell       Date:  2002-08       Impact factor: 4.138

Review 4.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

5.  p38γ regulates UV-induced checkpoint signaling and repair of UV-induced DNA damage.

Authors:  Chia-Cheng Wu; Xiaohua Wu; Jiahuai Han; Peiqing Sun
Journal:  Protein Cell       Date:  2010-06       Impact factor: 14.870

Review 6.  Analysis of mitogen-activated protein kinase activation and interactions with regulators and substrates.

Authors:  Lee Bardwell; Kandarp Shah
Journal:  Methods       Date:  2006-11       Impact factor: 3.608

7.  Mechanisms of MAPK signalling specificity.

Authors:  L Bardwell
Journal:  Biochem Soc Trans       Date:  2006-11       Impact factor: 5.407

8.  c-Myc potentiates the mitochondrial pathway of apoptosis by acting upstream of apoptosis signal-regulating kinase 1 (Ask1) in the p38 signalling cascade.

Authors:  Katia M Desbiens; Réna G Deschesnes; Mireille M Labrie; Yan Desfossés; Herman Lambert; Jacques Landry; Kerstin Bellmann
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

9.  The structure of the MAP2K MEK6 reveals an autoinhibitory dimer.

Authors:  Xiaoshan Min; Radha Akella; Haixia He; John M Humphreys; Susan E Tsutakawa; Seung-Jae Lee; John A Tainer; Melanie H Cobb; Elizabeth J Goldsmith
Journal:  Structure       Date:  2009-01-14       Impact factor: 5.006

10.  NRP-1 interacts with GIPC1 and SYX to activate p38 MAPK signaling and cancer stem cell survival.

Authors:  Daniel Grun; Gautam Adhikary; Richard L Eckert
Journal:  Mol Carcinog       Date:  2018-12-21       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.